title: The Role of Drug Exposure in Clinical Development: To What Extent Is Pharmacokinetic Assessment Needed in a Drug Development Programme?
authors.affiliation: Clinical Pharmacology, Modeling and Simulation, 709 Swedeland Road, King of Prussia, PA, 19406, USA. navingoyal@gmail.com.
authors.forename: Navin
authors.initials: N
authors.lastname: Goyal
mesh_terms: D001549:Benzamides; D001682:Biological Availability; D001698:Biomedical Engineering; D001702:Biopharmaceutics; D002986:Clinical Trials as Topic / Q000379:methods*; D015195:Drug Design; D004347:Drug Interactions; D006801:Humans; D009570:Nitriles; D010599:Pharmacokinetics; D010601:Pharmacology, Clinical; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D013810:Therapeutic Equivalency
chemical_list: D001549:Benzamides; D009570:Nitriles; D010669:Phenylthiohydantoin; C540278:enzalutamide